Hot Pursuit     30-Jun-23
Zydus Lifesciences Ltd soars 0.09%, rises for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 583, up 0.09% on the day as on 12:44 IST on the NSE. The stock is up 61.36% in last one year as compared to a 21.45% gain in NIFTY and a 12.38% gain in the Nifty Metal.

Zydus Lifesciences Ltd gained for a fifth straight session today. The stock is quoting at Rs 583, up 0.09% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.84% on the day, quoting at 19130.9. The Sensex is at 64495.2, up 0.91%. Zydus Lifesciences Ltd has added around 16.07% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has added around 8.68% in last one month and is currently quoting at 13622.75, up 1.15% on the day. The volume in the stock stood at 8.61 lakh shares today, compared to the daily average of 12.37 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 587.05, up 0.7% on the day. Zydus Lifesciences Ltd is up 61.36% in last one year as compared to a 21.45% gain in NIFTY and a 12.38% gain in the Nifty Metal index.

The PE of the stock is 35.02 based on TTM earnings ending March 23.

Previous News
  Sentynl (Zydus Group) receives USFDA approval for ZYCUBO®
 ( Corporate News - 13-Jan-26   14:01 )
  Zydus Lifesciences’ US arm secures FDA nod for ZYCUBO in Pediatric Menkes Patients
 ( Hot Pursuit - 13-Jan-26   11:17 )
  Zydus Lifesciences Ltd spurts 0.27%, up for fifth straight session
 ( Hot Pursuit - 06-Jan-26   13:00 )
  Zydus partners with Bioeq for licensing, supply and commercialization of Lucentis® in US market
 ( Corporate News - 23-Dec-25   19:05 )
  Zydus signs agreement with Myriad Genetics
 ( Corporate News - 19-Dec-25   10:22 )
  Sentynl announces USFDA Acceptance of CUTX-101 NDA resubmission
 ( Corporate News - 15-Dec-25   19:03 )
  Zydus Lifesciences gains after launching Denosumab Biosimilar
 ( Hot Pursuit - 10-Dec-25   11:27 )
  Zydus launches Zyrifa - a Denosumab biosimilar
 ( Corporate News - 10-Dec-25   10:19 )
  Zydus Lifesciences receives EIR for facility at Jarod, Vadodara
 ( Corporate News - 04-Dec-25   15:48 )
  Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi
 ( Hot Pursuit - 28-Nov-25   09:21 )
  Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product
 ( Hot Pursuit - 26-Nov-25   13:30 )
Other Stories
  Tech Mahindra Q3 PAT slips 6% QoQ to Rs 1,122 cr
  16-Jan-26   17:49
  Wipro Q3 PAT drops 4% QoQ to Rs 3119 cr
  16-Jan-26   17:02
  Central Bank of India gains after Q3 PAT climbs 32% YoY to Rs 1,262 cr
  16-Jan-26   15:15
  HBL Engineering Ltd leads losers in 'A' group
  16-Jan-26   15:00
  South Indian Bank jumps on record Q3 profit; asset quality and CASA improve
  16-Jan-26   14:58
  Krishival Foods Ltd Partly Paidup leads losers in 'B' group
  16-Jan-26   14:45
  Volumes jump at Indiamart Intermesh Ltd counter
  16-Jan-26   14:30
  Anand Rathi Share and Stock Brokers rallies after Q3 PAT climbs 72% YoY to Rs 37 cr
  16-Jan-26   14:08
  Sterling and Wilson Renewable clocks PAT of Rs 2 crore in Q3; raises orderbook guidance to Rs 11,000 crore
  16-Jan-26   13:23
  Nelco slumps on reporting dismal Q3 performance
  16-Jan-26   13:12
Back Top